Operating Expenses Summary of Qiagen N.V.

Qiagen N.V.'s latest annual operating expenses in 2023 was 777.67 Million USD , down -3.79% from previous year.
Qiagen N.V.'s latest quarterly operating expenses in 2024 Q2 was 192.4 Million USD , up 46.52% from previous quarter.
Qiagen N.V. reported a annual operating expenses of 808.33 Million USD in annual operating expenses 2022, up 1.94% from previous year.
Qiagen N.V. reported a annual operating expenses of 792.97 Million USD in annual operating expenses 2021, up 16.11% from previous year.
Qiagen N.V. reported a quarterly operating expenses of 192.4 Million USD for 2024 Q2, up 46.52% from previous quarter.
Qiagen N.V. reported a quarterly operating expenses of 204.95 Million USD for 2023 Q1, up 0.03% from previous quarter.

Annual Operating Expenses Chart of Qiagen N.V. (2023 - 1995)

Historical Annual Operating Expenses of Qiagen N.V. (2023 - 1995)

Year	Operating Expenses	Operating Expenses Growth
2023	777.67 Million USD	-3.79%
2022	808.33 Million USD	1.94%
2021	792.97 Million USD	16.11%
2020	682.94 Million USD	-1.25%
2019	691.58 Million USD	-5.83%
2018	734.37 Million USD	-4.52%
2017	769.14 Million USD	3.13%
2016	745.82 Million USD	14.62%
2015	650.68 Million USD	-7.59%
2014	704.12 Million USD	-6.39%
2013	752.16 Million USD	14.97%
2012	654.21 Million USD	0.61%
2011	650.22 Million USD	23.38%
2010	527.02 Million USD	8.25%
2009	486.86 Million USD	10.99%
2008	438.67 Million USD	45.47%
2007	301.55 Million USD	40.72%
2006	214.29 Million USD	23.22%
2005	173.91 Million USD	5.41%
2004	164.98 Million USD	5.05%
2003	157.06 Million USD	8.1%
2002	145.29 Million USD	11.23%
2001	130.62 Million USD	25.13%
2000	104.38 Million USD	22.28%
1999	85.36 Million USD	24.44%
1998	68.6 Million USD	34.77%
1997	50.9 Million USD	41.39%
1996	36 Million USD	46.34%
1995	24.6 Million USD	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	190.02 Million USD	-9.79%
2024 Q2	192.4 Million USD	46.52%
2023 Q1	204.95 Million USD	0.03%
2023 Q3	190.75 Million USD	-3.71%
2023 Q4	210.65 Million USD	10.43%
2023 FY	777.67 Million USD	-3.79%
2023 Q2	198.11 Million USD	-3.34%
2022 Q1	202.14 Million USD	2.23%
2022 Q4	204.89 Million USD	3.92%
2022 FY	808.33 Million USD	1.94%
2022 Q2	204.11 Million USD	0.97%
2022 Q3	197.17 Million USD	-3.4%
2021 Q2	198.88 Million USD	-0.76%
2021 Q4	197.73 Million USD	0.91%
2021 FY	792.97 Million USD	16.11%
2021 Q1	200.4 Million USD	-2.17%
2021 Q3	195.95 Million USD	-1.47%
2020 Q2	155.07 Million USD	-5.36%
2020 FY	682.94 Million USD	-1.25%
2020 Q1	163.85 Million USD	0.27%
2020 Q3	171.46 Million USD	10.57%
2020 Q4	204.84 Million USD	19.47%
2019 FY	691.58 Million USD	-5.83%
2019 Q1	183.68 Million USD	4.08%
2019 Q2	185.73 Million USD	1.12%
2019 Q3	173.74 Million USD	-6.46%
2019 Q4	163.41 Million USD	-5.95%
2018 Q4	176.48 Million USD	-1.81%
2018 Q3	179.74 Million USD	-10.32%
2018 Q2	200.42 Million USD	12.77%
2018 Q1	177.73 Million USD	-18.44%
2018 FY	734.37 Million USD	-4.52%
2017 Q1	172.09 Million USD	-23.11%
2017 Q4	217.9 Million USD	23.15%
2017 FY	769.14 Million USD	3.13%
2017 Q3	176.95 Million USD	-12.48%
2017 Q2	202.19 Million USD	17.49%
2016 Q4	223.81 Million USD	28.75%
2016 Q1	169.34 Million USD	0.26%
2016 Q2	181.41 Million USD	7.13%
2016 Q3	173.83 Million USD	-4.18%
2016 FY	745.82 Million USD	14.62%
2015 Q1	162.74 Million USD	-16.63%
2015 FY	650.68 Million USD	-7.59%
2015 Q3	158.47 Million USD	-1.29%
2015 Q2	160.55 Million USD	-1.34%
2015 Q4	168.91 Million USD	6.59%
2014 Q1	167.81 Million USD	-16.86%
2014 Q4	195.2 Million USD	12.89%
2014 FY	704.12 Million USD	-6.39%
2014 Q2	168.17 Million USD	0.22%
2014 Q3	172.92 Million USD	2.82%
2013 Q1	170.94 Million USD	-6.89%
2013 FY	752.16 Million USD	14.97%
2013 Q4	201.85 Million USD	14.5%
2013 Q3	176.28 Million USD	-13.19%
2013 Q2	203.07 Million USD	18.8%
2012 FY	654.21 Million USD	0.61%
2012 Q3	160.17 Million USD	1.67%
2012 Q2	157.54 Million USD	3.05%
2012 Q1	152.88 Million USD	-30.92%
2012 Q4	183.59 Million USD	14.62%
2011 Q4	221.32 Million USD	44.44%
2011 Q1	133.7 Million USD	-3.29%
2011 Q2	141.95 Million USD	6.17%
2011 FY	650.22 Million USD	23.38%
2011 Q3	153.23 Million USD	7.95%
2010 Q1	128.53 Million USD	-11.46%
2010 Q2	129.95 Million USD	1.11%
2010 Q3	130.28 Million USD	0.25%
2010 FY	527.02 Million USD	8.25%
2010 Q4	138.25 Million USD	6.12%
2009 Q2	112.61 Million USD	2.92%
2009 Q3	119.65 Million USD	6.25%
2009 FY	486.86 Million USD	10.99%
2009 Q4	145.17 Million USD	21.32%
2009 Q1	109.42 Million USD	-22.01%
2008 Q4	140.3 Million USD	38.66%
2008 FY	438.67 Million USD	45.47%
2008 Q1	-31.39 Million USD	-130.71%
2008 Q3	101.18 Million USD	-3.31%
2008 Q2	104.64 Million USD	433.31%
2007 FY	301.55 Million USD	40.72%
2007 Q4	102.24 Million USD	21.0%
2007 Q2	61 Million USD	3.31%
2007 Q1	59.05 Million USD	2.52%
2007 Q3	84.5 Million USD	38.51%
2006 Q4	57.6 Million USD	7.51%
2006 Q2	56.71 Million USD	13.6%
2006 Q1	49.92 Million USD	15.73%
2006 Q3	53.58 Million USD	-5.53%
2006 FY	214.29 Million USD	23.22%
2005 Q4	43.14 Million USD	0.88%
2005 FY	173.91 Million USD	5.41%
2005 Q1	43.02 Million USD	4.66%
2005 Q2	42.66 Million USD	-0.84%
2005 Q3	42.76 Million USD	0.22%
2004 Q4	41.11 Million USD	8.09%
2004 Q3	38.03 Million USD	-8.24%
2004 Q2	41.44 Million USD	-6.64%
2004 Q1	44.39 Million USD	5.29%
2004 FY	164.98 Million USD	5.05%
2003 FY	157.06 Million USD	8.1%
2003 Q2	38.77 Million USD	6.57%
2003 Q1	36.38 Million USD	-3.87%
2003 Q4	42.16 Million USD	6.08%
2003 Q3	39.74 Million USD	2.52%
2002 FY	145.29 Million USD	11.23%
2002 Q1	33.77 Million USD	5.65%
2002 Q2	36.19 Million USD	7.16%
2002 Q3	37.48 Million USD	3.57%
2002 Q4	37.84 Million USD	0.96%
2001 Q3	33.39 Million USD	7.64%
2001 FY	130.62 Million USD	25.13%
2001 Q4	31.96 Million USD	-4.27%
2001 Q1	34.34 Million USD	51.9%
2001 Q2	31.02 Million USD	-9.66%
2000 Q3	27.36 Million USD	1.04%
2000 FY	104.38 Million USD	22.28%
2000 Q4	22.6 Million USD	-17.39%
2000 Q2	27.08 Million USD	6.64%
2000 Q1	25.39 Million USD	12.92%
1999 FY	85.36 Million USD	24.44%
1999 Q1	20.4 Million USD	-14.64%
1999 Q2	20.5 Million USD	0.49%
1999 Q3	21.94 Million USD	7.05%
1999 Q4	22.49 Million USD	2.48%
1998 Q3	15.6 Million USD	6.12%
1998 Q2	14.7 Million USD	8.89%
1998 Q1	13.5 Million USD	-23.73%
1998 FY	68.6 Million USD	34.77%
1998 Q4	23.9 Million USD	53.21%
1997 Q2	11.3 Million USD	10.78%
1997 Q1	10.2 Million USD	121.16%
1997 Q4	17.7 Million USD	51.28%
1997 Q3	11.7 Million USD	3.54%
1997 FY	50.9 Million USD	41.39%
1996 Q4	-48.2 Million USD	0.0%
1996 Q1	7.8 Million USD	0.0%
1996 FY	36 Million USD	46.34%
1996 Q3	- USD	0.0%
1996 Q2	- USD	-100.0%
1995 FY	24.6 Million USD	0.0%

Peer Operating Expenses Comparison of Qiagen N.V.

Name	Operating Expenses	Operating Expenses Difference
Agilent Technologies, Inc.	2.11 Billion USD	63.23%
Charles River Laboratories International, Inc.	885.29 Million USD	12.156%
Quest Diagnostics Incorporated	1.61 Billion USD	51.697%
Danaher Corporation	8.83 Billion USD	91.195%
Enzo Biochem, Inc.	26.99 Million USD	-2780.605%
IQVIA Holdings Inc.	2.05 Billion USD	62.12%
Laboratory Corporation of America Holdings	2.02 Billion USD	61.528%
Mettler-Toledo International Inc.	1.08 Billion USD	28.614%
Revvity, Inc.	874.01 Million USD	11.023%
Thermo Fisher Scientific Inc.	10.25 Billion USD	92.416%
Waters Corporation	943.51 Million USD	17.577%

Global Stocks Search

Qiagen N.V. (QGEN)

Operating Expenses Summary of Qiagen N.V.

Annual Operating Expenses Chart of Qiagen N.V. (2023 - 1995)

Historical Annual Operating Expenses of Qiagen N.V. (2023 - 1995)

Peer Operating Expenses Comparison of Qiagen N.V.